Teladoc Health to Participate in Upcoming Investor Conference
Get Alerts TDOC Hot Sheet
Join SI Premium – FREE
PURCHASE, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Jason Gorevic, chief executive officer, and Mala Murthy, chief financial officer, will participate in the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021, at 10:00 a.m. ET. A live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations/.
About Teladoc Health
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Ranked Best in KLAS for Virtual Care Platforms in 2020, Teladoc Health leverages more than a decade of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com or follow @TeladocHealth on Twitter.
Investor Contact: Patrick Feeley 914-265-7925 [email protected] Media Contact: Chris Stenrud [email protected] 860-491-8821Source: Teladoc Health, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kelley Drye Congratulates the State of New Jersey on the Approval of Its Historic PFAS Settlements Valued at Approximately $2.5 Billion
- Vivakor Accelerates Crude Oil Trading Portfolio toward $2 Billion in Annualized Commercial Activity
- Claremedica Able to Detect 90% of Dementia Cases at the Earliest Stage After Adopting Creyos' Digital Cognitive Testing
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
JPMorgan, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share